Cardiovascular and autonomic phenotype of db/db diabetic mice

被引:84
作者
Senador, Danielle
Kanakamedala, Keerthy
Irigoyen, Maria Claudia [2 ]
Morris, Mariana
Elased, Khalid M. [1 ]
机构
[1] Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA
[2] Univ Sao Paulo, Sch Med, Hypertens Unit, Inst Heart InCor, Sao Paulo, Brazil
关键词
HEART-RATE-VARIABILITY; BETA-CELL FUNCTION; BLOOD-PRESSURE; RECEPTOR ANTAGONISM; GLUCOSE-TOLERANCE; SPECTRAL-ANALYSIS; ANGIOTENSIN; LOSARTAN; INSULIN; HYPERTENSION;
D O I
10.1113/expphysiol.2008.046474
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The db/db mice serve as a good model for type 2 diabetes characterized by hyperinsulinaemia and progressive hyperglycaemia. There are limited and conflicting data on the cardiovascular changes in this model. The aim of the present study was to characterize the cardiovascular and autonomic phenotype of male db/db mice and evaluate the role of angiotensin II AT(1) receptors. Radiotelemetry was used to monitor 24 h blood pressure (BP) in mice for 8 weeks. Parameters measured were mean arterial pressure (MAP), heart rate (HR) and their variabilities. In 8-week-old db/db mice, the MAP and BP circadian rhythms were not different from age-matched control mice, while HR and locomotor activity were decreased. With ageing, MAP gradually increased in db/db mice, and the 12 h light values did not dip significantly from the 12 h dark periods. In 14-week-old mice, MAP was increased during light (101 +/- 1 versus 117 +/- 2 mmHg, P < 0.01; control versus db/db mice) and dark phases (110 +/- 1.7 versus 121 +/- 3.1 mmHg, P < 0.01; control versus db/db mice). This increase in MAP was associated with a significant increase in plasma angiotensin-converting enzyme activity and angiotensin II levels. Chronic treatment with losartan (10 mg kg(-1) day(-1)) blocked the increase in MAP in db/db mice, with no effect in control animals. Spectral analysis was used to monitor autonomic cardiovascular function. The circadian rhythm observed in systolic arterial pressure variance and its low-frequency component in control mice was absent in db/db mice. There were no changes in HR variability and spontaneous baroreflex sensitivity between control and db/db mice. The results document an age-related increase in MAP in db/db mice, which can be reduced by antagonism of angiotensin II AT(1) receptors, and alterations in autonomic balance and components of the renin-angiotensin system.
引用
收藏
页码:648 / 658
页数:11
相关论文
共 58 条
[11]   Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice [J].
Chen, H ;
Charlat, O ;
Tartaglia, LA ;
Woolf, EA ;
Weng, X ;
Ellis, SJ ;
Lakey, ND ;
Culpepper, J ;
Moore, KJ ;
Breitbart, RE ;
Duyk, GM ;
Tepper, RI ;
Morgenstern, JP .
CELL, 1996, 84 (03) :491-495
[12]   Angiotensin II type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes [J].
Chu, KY ;
Lau, T ;
Carlsson, PO ;
Leung, PS .
DIABETES, 2006, 55 (02) :367-374
[13]   OBESE AND DIABETES - 2 MUTANT-GENES CAUSING DIABETES-OBESITY SYNDROMES IN MICE [J].
COLEMAN, DL .
DIABETOLOGIA, 1978, 14 (03) :141-148
[14]   LESSONS FROM STUDIES WITH GENETIC FORMS OF DIABETES IN THE MOUSE [J].
COLEMAN, DL .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (07) :162-164
[15]   Intensive glycemic control in the ACCORD and ADVANCE trials [J].
Dluhy, Robert G. ;
McMahon, Graham T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24) :2630-2633
[16]   Molecular activation of PPARγ by angiotensin II type 1-receptor antagonists [J].
Erbe, David V. ;
Gartrell, Katherine ;
Zhang, Yan-Ling ;
Suri, Vipin ;
Kirincich, Steven J. ;
Will, Sarah ;
Perreault, Mylene ;
Wang, Suyue ;
Tobin, James F. .
VASCULAR PHARMACOLOGY, 2006, 45 (03) :154-162
[17]   Genetic and dietary interactions:: role of angiotensin AT1a receptors in response to a high-fructose diet [J].
Farah, Vera ;
Elased, Khalid M. ;
Morris, Mariana .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (02) :H1083-H1089
[18]   Nocturnal hypertension in mice consuming a high fructose diet [J].
Farah, Vera ;
Elased, Khalid M. ;
Chen, Yanfang ;
Key, Mary P. ;
Cunha, Tatiana S. ;
Irigoyen, Maria Claudia ;
Morris, Mariana .
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2006, 130 (1-2) :41-50
[19]   ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients [J].
Fogari, R ;
Zoppi, A ;
Lazzari, P ;
Preti, P ;
Mugellini, A ;
Corradi, L ;
Lusardi, P .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 (04) :616-620
[20]   Glycemia treatment strategies in the action to control cardiovascular risk in diabetes (ACCORD) trial [J].
Gerstein, Hertzel C. ;
Riddle, Matthew C. ;
Kendall, David M. ;
Cohen, Robert M. ;
Goland, Robin ;
Feinglos-, Mark N. ;
Kirk, Julienne K. ;
Hamilton, Bruce P. ;
Ismail-Beigi, Faramarz ;
Feeney, Patricia .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A) :34I-43I